BIOCHEMISTRY • LIPID AND AMINO ACID METABOLISM

Ketone Bodies: Formation and Utilization

How the liver converts fatty acids into water-soluble fuel for the brain and other tissues during metabolic stress.

Historical Context & Motivation

The discovery of ketone bodies arose from clinical observations of patients with uncontrolled diabetes mellitus. In the late nineteenth century, physicians noted a characteristic fruity odor on the breath of severely diabetic patients and detected unusual substances in their urine. These substances, initially regarded as pathological waste products, were later recognized as critical metabolic intermediates that serve as alternative fuels when glucose availability is limited. The evolution of our understanding of ketone bodies illustrates a broader theme in biochemistry: molecules once dismissed as toxic byproducts often turn out to play essential physiological roles. Today, ketogenesis and ketolysis are recognized as indispensable components of whole-body energy homeostasis, particularly during fasting, prolonged exercise, and the neonatal period.

1886
First Chemical Identification
Gerhardt detects acetone in the urine of diabetic patients, establishing the first chemical link between diabetes and what would later be termed ketonuria. This observation catalyzed research into the metabolic origins of these compounds.
1940s
Krebs and the Biochemical Pathway
Hans Krebs and colleagues elucidate the enzymatic steps of ketogenesis in liver mitochondria, establishing that acetoacetate and β-hydroxybutyrate are synthesized from acetyl-CoA derived from fatty acid β-oxidation.
1967
Brain Utilization Demonstrated
George Cahill's landmark starvation studies demonstrate that the human brain can derive up to 75% of its energy from ketone bodies during prolonged fasting, overturning the longstanding dogma that the brain relies exclusively on glucose.
1990s–Present
Therapeutic and Signaling Roles
Research reveals that ketone bodies function not only as fuels but also as signaling molecules that modulate gene expression, inflammation, and oxidative stress. Ketogenic diets gain renewed clinical interest for epilepsy, neurodegeneration, and metabolic syndrome.

A central question in metabolic biochemistry thus emerges: how does the liver synthesize ketone bodies from fatty acid–derived acetyl-CoA, and how do extrahepatic tissues capture and oxidize these molecules to generate ATP? Understanding ketogenesis and ketolysis requires integrating knowledge of β-oxidation, the citric acid cycle, and hormonal regulation into a coherent picture of metabolic adaptation.

Core Principles & Definitions

Before diving into the enzymatic details of ketone body metabolism, it is essential to establish several foundational concepts. The three ketone bodies—acetoacetate (AcAc), D-β-hydroxybutyrate (BHB), and acetone—are water-soluble, lipid-derived molecules synthesized in the mitochondrial matrix of hepatocytes. Although the term "ketone body" is a historical convention (BHB is technically a hydroxy acid, not a ketone), these three compounds are grouped together because they share a common biosynthetic origin and metabolic logic. The following principles govern their formation and utilization.

1

Hepatic Synthesis, Extrahepatic Oxidation

The liver produces ketone bodies but cannot oxidize them because it lacks the enzyme succinyl-CoA:3-oxoacid CoA transferase (SCOT). This metabolic asymmetry ensures net export of ketone bodies to tissues such as the brain, heart, and skeletal muscle.
2

Acetyl-CoA as the Central Precursor

All three ketone bodies originate from acetyl-CoA generated primarily by fatty acid β-oxidation. When oxaloacetate is depleted (redirected to gluconeogenesis), acetyl-CoA accumulates and is channeled into ketogenesis rather than the TCA cycle.
3

Hormonal Regulation

A high glucagon-to-insulin ratio promotes lipolysis in adipose tissue, increases hepatic β-oxidation, and activates the ketogenic enzyme HMG-CoA synthase. Insulin suppresses all three processes.
4

Physiological vs. Pathological Ketosis

During fasting, blood ketone levels rise to 2–5 mM (physiological ketosis). In uncontrolled type 1 diabetes, levels can exceed 20 mM, producing life-threatening diabetic ketoacidosis (DKA) with dangerous drops in blood pH.
KEY TAKEAWAY
Think of the liver as a fuel refinery that converts bulky, water-insoluble fatty acids into compact, water-soluble ketone bodies—small molecules that can travel freely through the bloodstream and cross the blood–brain barrier. The refinery itself never burns the product it makes; instead, it ships all the fuel to downstream consumers like the brain and heart.

The Ketogenesis Pathway — Visual Overview

The ketogenesis pathway proceeds in four enzymatic steps within the hepatic mitochondrial matrix. Two molecules of acetyl-CoA are condensed by thiolase to form acetoacetyl-CoA, which is then converted to HMG-CoA by the rate-limiting enzyme HMG-CoA synthase. HMG-CoA lyase cleaves HMG-CoA to yield acetoacetate, which can be reduced to D-β-hydroxybutyrate or spontaneously decarboxylated to acetone.

As illustrated in the diagram above, the pathway begins with the condensation of two acetyl-CoA molecules by thiolase (also called acetyl-CoA acetyltransferase), producing acetoacetyl-CoA. A third acetyl-CoA is added by HMG-CoA synthase to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). This is the committed and rate-limiting step. HMG-CoA lyase then cleaves HMG-CoA into acetoacetate and acetyl-CoA. The acetoacetate can either be reduced to D-β-hydroxybutyrate by β-hydroxybutyrate dehydrogenase (consuming NADH) or undergo non-enzymatic decarboxylation to acetone. Under physiological conditions, the BHB-to-AcAc ratio reflects the mitochondrial NADH/NAD⁺ ratio and typically ranges from 1:1 during mild fasting to as high as 6:1 during prolonged starvation.

Enzymatic Mechanisms & Regulation

The regulation of ketogenesis is a multi-layered process that integrates hormonal signals, substrate availability, and allosteric control. Understanding these layers is critical because ketone body production must be tightly matched to whole-body fuel needs: too little leads to energy crisis during starvation, while too much produces the dangerous metabolic acidosis seen in DKA.

Level 1: Hormonal Control of Fatty Acid Supply

The primary determinant of ketogenic rate is the flux of free fatty acids (FFAs) arriving at the liver from adipose tissue. During fasting, a falling insulin-to-glucagon ratio activates hormone-sensitive lipase (HSL) in adipocytes, releasing FFAs into the bloodstream. These FFAs are taken up by hepatocytes, activated to fatty acyl-CoA, and transported into the mitochondrial matrix via the carnitine shuttle (CPT-I and CPT-II). In the fed state, insulin suppresses HSL and upregulates malonyl-CoA production (via acetyl-CoA carboxylase), which inhibits CPT-I and thereby blocks fatty acid entry into the mitochondrion.

Level 2: Intramitochondrial Regulation

Once fatty acyl-CoA enters the mitochondrial matrix and undergoes β-oxidation, the resulting acetyl-CoA faces a metabolic branch point. If oxaloacetate (OAA) is available, acetyl-CoA enters the TCA cycle via citrate synthase. However, during fasting and gluconeogenesis, OAA is siphoned away to make glucose (via PEPCK), starving the TCA cycle of this key intermediate. The resulting surplus of acetyl-CoA is diverted into ketogenesis. The mitochondrial HMG-CoA synthase is the committed step and is regulated both transcriptionally (via PPARα and FOXA2) and by succinylation: succinyl-CoA covalently modifies the enzyme's active-site cysteine, inactivating it. When TCA cycle intermediates are depleted, succinyl-CoA levels fall, relieving this inhibition and stimulating ketogenesis.

NET KETOGENESIS STOICHIOMETRY
2 Acetyl-CoA + H₂O → Acetoacetate + 2 CoA-SH
Although three acetyl-CoA molecules are consumed by HMG-CoA synthase, one is regenerated by HMG-CoA lyase, yielding a net consumption of two acetyl-CoA per acetoacetate produced.
BHB DEHYDROGENASE EQUILIBRIUM
Acetoacetate + NADH + H⁺ ⇌ D-β-Hydroxybutyrate + NAD⁺
The ratio [BHB]/[AcAc] is directly proportional to the mitochondrial [NADH]/[NAD⁺] ratio. In prolonged starvation, elevated NADH from β-oxidation pushes this equilibrium toward BHB, which becomes the dominant circulating ketone body.

Level 3: Malonyl-CoA as a Key Switch

The concentration of malonyl-CoA in the hepatocyte cytoplasm serves as a reciprocal switch between fatty acid synthesis and oxidation. In the fed state, insulin activates acetyl-CoA carboxylase (ACC), raising malonyl-CoA levels, which potently inhibits CPT-I and prevents fatty acid entry into the mitochondrion. During fasting, glucagon-stimulated AMPK phosphorylates and inactivates ACC, causing malonyl-CoA to fall and CPT-I to become fully active. This elegant mechanism ensures that the liver does not simultaneously synthesize and oxidize fatty acids.

Ketone Body Utilization (Ketolysis)

While the liver is the primary site of ketone body production, it is the extrahepatic tissues—particularly the brain, heart, skeletal muscle, and renal cortex—that oxidize ketone bodies for energy. The pathway of ketolysis essentially reverses ketogenesis, converting acetoacetate back into two molecules of acetyl-CoA that enter the TCA cycle. The critical enzyme that enables this process, SCOT, is absent in the liver, which is why hepatocytes cannot utilize their own product.

The ketolysis pathway in extrahepatic tissues: D-β-hydroxybutyrate is first oxidized back to acetoacetate by BHB dehydrogenase (generating NADH). SCOT then transfers a CoA group from succinyl-CoA to acetoacetate, forming acetoacetyl-CoA, which thiolase cleaves into two acetyl-CoA molecules for the TCA cycle.

ATP Yield from Ketone Body Oxidation

The complete oxidation of one molecule of D-β-hydroxybutyrate yields approximately 21.5 ATP (using the revised P/O ratios of 2.5 for NADH and 1.5 for FADH₂). The BHB dehydrogenase reaction generates 1 NADH (≈ 2.5 ATP). SCOT does not consume or produce high-energy intermediates directly but diverts one succinyl-CoA away from the GTP-generating succinyl-CoA synthetase step, incurring a cost of 1 GTP (≈ 1 ATP). Thiolase produces two acetyl-CoA molecules, each of which generates 10 ATP via the TCA cycle and oxidative phosphorylation. Therefore: 2.5 + 2 × 10 − 1 = 21.5 ATP per BHB. Acetoacetate oxidation yields approximately 20 ATP because it skips the initial NADH-generating step.

ATP YIELD FROM BHB
1 BHB → 1 NADH + 2 Acetyl-CoA (via TCA) − 1 GTP ≈ 21.5 ATP
1 NADH ≈ 2.5 ATP; each acetyl-CoA → ≈ 10 ATP via TCA + oxidative phosphorylation; 1 GTP equivalent consumed by SCOT bypassing succinyl-CoA synthetase.

Worked Example: ATP from Ketone Bodies During Fasting

Consider the following problem: A patient has been fasting for 48 hours and has a plasma β-hydroxybutyrate concentration of 4 mM. If the brain oxidizes 35 g of β-hydroxybutyrate per day under these conditions, how many moles of ATP are generated, and how does this compare to the ATP yield from an equivalent mass of glucose?

ATP Yield from Cerebral BHB Oxidation During Fasting
1
Step 1 — Calculate Moles of BHB OxidizedThe molecular weight of D-β-hydroxybutyrate (C₄H₇O₃⁻) is approximately 104 g/mol (as the free acid form). Therefore: moles of BHB = 35 g ÷ 104 g/mol.
0.337 mol BHB
2
Step 2 — Determine ATP per Mole of BHBAs established in Section 5, the complete oxidation of one mole of D-β-hydroxybutyrate yields approximately 21.5 mol ATP. This accounts for the NADH produced by BHB dehydrogenase (2.5 ATP), two acetyl-CoA molecules entering the TCA cycle (2 × 10 = 20 ATP), and the loss of one GTP equivalent from the SCOT reaction (−1 ATP).
21.5 mol ATP per mol BHB
3
Step 3 — Calculate Total ATP from BHBTotal ATP = 0.337 mol × 21.5 mol ATP/mol = 7.24 mol ATP from BHB oxidation per day.
≈ 7.24 mol ATP per day
4
Step 4 — Compare to GlucoseFor an equivalent mass of glucose (35 g, MW = 180 g/mol): moles of glucose = 35 ÷ 180 = 0.194 mol. Complete oxidation of glucose yields approximately 30–32 ATP per molecule (using revised P/O ratios). Taking 30.5 as an average: total ATP from glucose = 0.194 × 30.5 = 5.92 mol ATP.
≈ 5.92 mol ATP from glucose
5
Step 5 — Interpret the ResultGram for gram, BHB yields more ATP than glucose (7.24 vs. 5.92 mol for 35 g), reflecting the more reduced carbon skeleton of BHB. This higher energy density makes ketone bodies an efficient alternative fuel, explaining why the brain adapts to use them extensively during prolonged fasting—thereby sparing muscle protein from gluconeogenesis.
BHB is ≈ 22% more energy-dense per gram than glucose

Physiological Ketosis vs. Diabetic Ketoacidosis

A common source of confusion for students and clinicians alike is the distinction between physiological ketosis and diabetic ketoacidosis (DKA). Although both involve elevated circulating ketone bodies, they differ dramatically in magnitude, etiology, and clinical consequences. The following table highlights the key differences.

Comparison of physiological ketosis and diabetic ketoacidosis
FeaturePhysiological KetosisDiabetic Ketoacidosis
Blood ketone level1–5 mM>10 mM, often 15–25 mM
Blood pHNormal (7.35–7.45)<7.30 (metabolic acidosis)
Insulin levelLow but present; sufficient to restrain lipolysisAbsent or severely deficient
Glucose levelLow-normal (3.5–5.0 mM)Markedly elevated (>14 mM / 250 mg/dL)
TriggerFasting, ketogenic diet, prolonged exerciseAbsolute insulin deficiency (type 1 DM), illness
Self-limiting?Yes — ketone bodies stimulate residual insulin secretion, which limits further lipolysisNo — no insulin brake; positive feedback loop of lipolysis and ketogenesis
TreatmentNone required; resolves with carbohydrate intakeIV insulin, fluids, electrolyte replacement — medical emergency
KEY TAKEAWAY
Physiological ketosis is like a thermostat-controlled furnace: the body turns up ketone production when glucose runs low, and the remaining insulin acts as a thermostat to prevent overproduction. DKA is what happens when the thermostat breaks entirely—the furnace runs without restraint, flooding the system with acidic ketone bodies and driving blood pH to dangerous levels.

Beyond Fuel: Signaling and Epigenetic Roles of Ketone Bodies

Recent research has revealed that ketone bodies are far more than simple metabolic fuels. They function as signaling molecules and epigenetic modulators with implications for inflammation, aging, and neurological disease. β-Hydroxybutyrate, in particular, has emerged as a pleiotropic molecule that influences gene expression, redox balance, and cell signaling through mechanisms that are largely independent of its role as an energy substrate.

Non-metabolic roles of β-hydroxybutyrate
RoleMechanismBiological Significance
HDAC inhibitionBHB inhibits class I and IIa histone deacetylases (HDACs), promoting histone acetylationUpregulates oxidative stress resistance genes (FOXO3a, MT2, SOD2), linking fasting to cellular protection
NLRP3 inflammasome suppressionBHB inhibits the NLRP3 inflammasome via K⁺ efflux–independent mechanismsAnti-inflammatory effects observed in gout, Alzheimer's, and atherosclerosis models
GPR109A agonismBHB activates the Gᵢ-coupled receptor GPR109A (HCAR2) on adipocytes and immune cellsProvides negative feedback on lipolysis; neuroprotective effects in stroke models
β-HydroxybutyrylationBHB-derived moieties are covalently attached to histone lysine residues (Kbhb marks)Represents a novel post-translational modification that regulates gene transcription during starvation

These discoveries connect ketone body metabolism to broader themes in cell biology and medicine. In advanced courses, you will encounter these signaling roles in the context of caloric restriction mimetics, intermittent fasting, and therapeutic ketogenic diets. The emerging picture suggests that the metabolic shift toward ketogenesis during fasting activates a coordinated cellular defense program—what some researchers call the fasting–refeeding adaptive stress response—that may underlie many of the health benefits associated with dietary restriction.

Practice Problems

PROBLEM 1CONCEPTUAL
Explain why the liver produces ketone bodies but cannot use them for its own energy needs. What is the biochemical basis for this metabolic asymmetry, and what advantage does it confer?
PROBLEM 2BASIC CALCULATION
How many moles of acetyl-CoA are needed to produce 5 moles of acetoacetate via the ketogenesis pathway? Show your reasoning.
PROBLEM 3INTERMEDIATE
During prolonged fasting, a patient's blood [BHB]/[AcAc] ratio increases from 1:1 to 6:1. Explain this shift in terms of the mitochondrial redox state and the equilibrium of BHB dehydrogenase. Why does prolonged β-oxidation drive this ratio upward?
PROBLEM 4APPLIED
A patient with uncontrolled type 1 diabetes presents with blood glucose of 28 mM, blood ketone bodies at 18 mM, and arterial pH of 7.10. Explain the metabolic chain of events leading to this presentation, starting from insulin deficiency. Why is blood glucose elevated simultaneously with high ketone body levels, even though both represent metabolic fuels?
PROBLEM 5CRITICAL THINKING
The enzyme SCOT (succinyl-CoA:3-oxoacid CoA transferase) transfers a CoA group from succinyl-CoA to acetoacetate, effectively bypassing the succinyl-CoA synthetase step of the TCA cycle. Some biochemistry textbooks state this represents an 'energy cost' of ketone body utilization. Critically evaluate this claim. Is the cost real, and if so, is it appropriate to describe it as an ATP loss? Consider what happens to the succinate produced by SCOT.

Lesson Summary

Ketone bodiesacetoacetate, D-β-hydroxybutyrate, and acetone—are water-soluble fuels synthesized in the hepatic mitochondrial matrix from acetyl-CoA derived primarily from fatty acid β-oxidation. The pathway—ketogenesis—is driven by a high glucagon-to-insulin ratio and the diversion of oxaloacetate toward gluconeogenesis, which starves the TCA cycle and channels surplus acetyl-CoA into ketone body formation via the rate-limiting enzyme HMG-CoA synthase.

Extrahepatic tissues oxidize ketone bodies through ketolysis, a process requiring the enzyme SCOT (absent in the liver, ensuring net export). One molecule of BHB yields approximately 21.5 ATP, making it more energy-dense per gram than glucose. Physiological ketosis during fasting (1–5 mM) is a normal adaptive response, whereas diabetic ketoacidosis (>10 mM, pH < 7.30) is a life-threatening emergency caused by absolute insulin deficiency. Beyond their role as fuels, ketone bodies serve as signaling molecules that inhibit HDACs, suppress inflammation, and introduce novel histone modifications—connecting fasting metabolism to gene regulation and cellular protection.

Varsity Tutors • Biochemistry • Ketone Bodies: Formation and Utilization